Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,384 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06324201Recruiting
Long-term safety of a new ablation system for paroxysmal AF
This study tests a new system (QDOT MICRO and VISITAG SURPOINT) used during a catheter ablation procedure to treat atrial fibrillation (AF). It aims to see how safe and effective it is over the long term for people whose AF comes and goes and hasn't been controlled by medication.
Birmingham, AlabamaAges 18 years+ - NCT06325384Recruiting
Testing a contactless blood pressure monitor for home use
This trial tests a new, no-contact device called Lifelight that measures your blood pressure just by looking at your face. It compares these readings to the standard cuff method, and you can use it at home for self-monitoring.
LondonAges 18–100 - NCT06325280Recruiting
Exercise MRI for Kids with Heart Conditions
This study uses an MRI while exercising to check heart and lung fitness in children with heart disease. It helps doctors learn more about how to care for kids who have had a heart transplant or were born with heart problems.
Edmonton, AlbertaAges 10–18 - NCT06578702Recruiting
Intermittent HIV triple therapy study in real life
This study looks at how well intermittent triple therapy works for people with HIV in real-world settings. It may help researchers understand if taking breaks from standard treatment is safe and effective.
StrasbourgAges 18 years+ - NCT06455384Recruiting
Studying a digital tool for genetic testing services
This trial tests a new online tool called the Genetics Navigator, which helps people access genetic testing services more easily. If you or your child have been referred for genetic testing at Mount Sinai Hospital or SickKids in Toronto, this study may help you manage the process online.
Toronto, OntarioAges 18 years+ - NCT07694843RecruitingPhase 1
Study of ammoxetine for people with mild to moderate liver problems
This trial tests how the body processes ammoxetine in people with mild or moderate liver impairment compared to people with normal liver function. It aims to find out if the drug is safe and how it works in these groups.
Suzhou, JiangsuAges 18–75 - NCT06033950RecruitingPhase 3
A study of finerenone for heart failure patients who can't take standard MRA drugs
This study tests whether finerenone, a new type of drug, can help people with heart failure who cannot take standard steroid-based MRAs (a kind of heart medication) because of side effects or other reasons. It aims to see if it improves symptoms and is safe for you.
Fairhope, AlabamaAges 18 years+ - NCT07696130Recruiting
Trifocal lens implant study for cataract or presbyopia
This study tests a new type of trifocal lens implant to see how well it improves vision at all distances after cataract or lens replacement surgery. It may help you become less dependent on glasses.
Szczecin, ZachodnipomorskieAges 50–75 - NCT07696286Recruiting
Alexithymia in chronic pain patients with a spinal cord stimulator
This study looks at a condition called alexithymia (difficulty identifying and describing emotions) in people who have chronic pain and a spinal cord stimulator. It aims to help doctors better understand how emotions affect pain treatment.
IstanbulAges 18 years+ - NCT07694583Recruiting
Vitamin E dressing for pressure ulcer healing study
This trial tests a special dressing containing vitamin E (tocotrienols) to help heal pressure ulcers (bedsores) in stages 1 or 2. It aims to see if this dressing can speed up wound healing over 6 months.
Kuala Lumpur, SelangorAges 18 years+ - NCT07052578Recruiting
Aggressive prostate cancer study with HRR blood test
This study looks at men with aggressive, high-volume metastatic prostate cancer that is still sensitive to hormone therapy. It will analyze a blood test for HRR gene mutations (like BRCA) to help understand treatment patterns.
ArkhangelskAges 18 years+ - NCT07523581RecruitingPhase 2
Exaluren for Alport Syndrome Kidney Disease
This study tests whether a new medication called exaluren can slow kidney damage in people with Alport Syndrome caused by specific genetic mutations. Alport Syndrome is a genetic condition that damages the kidneys, and this trial aims to see if exaluren can help preserve kidney function and reduce protein loss in urine.
Los Angeles, CaliforniaAges 12 years+ - NCT07089576Recruiting
Study of the Arcevo LSA device for aortic arch repair
This trial tests a new device called Arcevo LSA to treat certain types of aortic arch problems, like dissections (tears) or aneurysms (bulges). It is for people who need open surgery, and the device helps fix the left subclavian artery area.
Birmingham, AlabamaAges 18–80 - NCT07454187RecruitingPhase 1/Phase 2
SG2918 for relapsed or refractory multiple myeloma
This trial tests a new drug called SG2918 for people with multiple myeloma that has come back or stopped responding to treatment. It aims to see if the drug is safe and possibly effective.
Zhengzhou, HenanAges 18–80 - NCT07692763Recruiting
Evaluating the YATAC program for young adults with cancer
This trial is testing a program called YATAC for young adults aged 18-39 who have been treated for cancer. It looks at how well the program works for people who have finished or are still in treatment and have been referred to cancer rehab services.
AarhusAges 18–39 - NCT07483710Recruiting
CT scan muscle test in ICU for septic shock
This study looks at whether a CT scan of the lower back muscle, taken when you first arrive in the intensive care unit for septic shock, can help predict recovery three months later. It may help doctors better understand how muscle health affects survival.
LyonAges 18 years+ - NCT06972446RecruitingPhase 2
Study of targeted therapies for rheumatoid arthritis
This trial tests different targeted treatments for people with rheumatoid arthritis who have tried one or two biologic or targeted synthetic drugs but still have symptoms. You need to be taking a stable dose of methotrexate.
Peoria, ArizonaAges 18 years+ - NCT07687576RecruitingPhase 2/Phase 3
Comparing clot removal methods for heart attack patients
This trial tests if a special device that sucks out blood clots during a heart attack is better than standard care for reducing clot size before placing a stent. It may help patients who have a large clot and a blocked artery.
Oxford, OxfordshireAges 18 years+ - NCT06326476RecruitingEarly Phase 1
Siplizumab injection for moderate to severe hidradenitis suppurativa
This study tests an injected drug called siplizumab for people with moderate to severe hidradenitis suppurativa (HS) that hasn't improved with other treatments. The goal is to see if it safely reduces painful bumps and improves your skin condition.
Birmingham, AlabamaAges 18 years+ - NCT06326567Recruiting
Support program for cancer patients with social needs
This trial tests a program that connects newly diagnosed cancer patients who have social needs (like food, housing, or transportation) with support services. It aims to improve your care by addressing these needs early.
Lexington, KentuckyAges 18 years+ - NCT06327451RecruitingPhase 2
Atorvastatin plus temozolomide for EGFR-positive glioblastoma
This trial tests whether adding the cholesterol drug atorvastatin to the standard chemotherapy temozolomide improves outcomes for people with a specific type of glioblastoma (brain cancer) that is positive for the EGFR protein. It aims to find a more effective treatment for this aggressive tumor.
TianjinAges 18–60 - NCT06327490RecruitingPhase 2
ICG-guided vs. traditional lymphatic drainage for breast cancer surgery
This trial compares a new imaging method (ICG) to the standard method for manual lymphatic drainage during breast cancer surgery. It aims to reduce swelling in the arm after lymph node removal.
Gainesville, FloridaAges 18–99 - NCT06328712RecruitingPhase 1/Phase 2
Cell therapy for Charcot-Marie-Tooth type 1A (CMT1A)
This trial tests a new cell therapy called EN001 for people with CMT1A. It aims to see if the treatment is safe and can help with nerve function and muscle weakness.
GyeongjuAges 19 years+ - NCT06330688Recruiting
Ultrasound-guided gallbladder drainage study
This study tests a specific technique for draining the gallbladder using ultrasound guidance. It aims to see if this method is safe and effective for people who need this procedure.
Chaïdári, AthensAges 18 years+
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,384 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.